CD44 and breast cancer: According to our results, HA-FeOOH@PPy NRs have shown great binding capacities with CD44-positive breast cancers, and HA-FeOOH@PPy NRs-mediated PTT has led to a selective destruction of CD44-positive breast cancer cells.